Ashwini Agarwal, Founder & Partner at Demeter Advisors, advised a stock-specific approach within FMCG, stayed constructive on pharmaceutical innovation, cautioned against long-term calls on metals due to commodity uncertainty, and said AI has made him reluctant to invest in IT despite attractive valuations.
